ASSOCIATION BETWEEN FOXP3 (RS3761548) PROMOTER POLYMORPHISM WITH VITILIGO PATIENTS, THEIR CLINICAL DATA AND RESPONSE TO PHOTOTHERAPY: A STUDY FROM EGYPT

Maha Abdelsalam; Marwa Zohdy; Mona Wassefy; Azza Salamony; shaimaa mohsen; Eman Elmansoury; Maged Mostafa

doi:10.21608/bfsa.2022.271657

Q4 2022

ASSOCIATION BETWEEN FOXP3 (RS3761548) PROMOTER POLYMORPHISM WITH VITILIGO PATIENTS, THEIR CLINICAL DATA AND RESPONSE TO PHOTOTHERAPY: A STUDY FROM EGYPT

Maha Abdelsalam · Marwa Zohdy · Mona Wassefy · Azza Salamony · shaimaa mohsen · Eman Elmansoury · Maged Mostafa

10.21608/bfsa.2022.271657 383 Views 2 Citations

Citations

383

Views

Abstract not available for this publication.

Cite this Article (APA)

Maha, A., Marwa, Z., Mona, W., Azza, S., shaimaa, M., Eman, E., Maged, M. (2022). ASSOCIATION BETWEEN FOXP3 (RS3761548) PROMOTER POLYMORPHISM WITH VITILIGO PATIENTS, THEIR CLINICAL DATA AND RESPONSE TO PHOTOTHERAPY: A STUDY FROM EGYPT. Bulletin of Pharmaceutical Sciences Assiut. https://doi.org/10.21608/bfsa.2022.271657